2 | | - | BY SENATOR(S) Ginal, Marchman, Buckner, Fields, Gardner, Kirkmeyer, |
---|
3 | | - | Liston, Lundeen, Pelton R., Rich, Smallwood, Will, Zenzinger; |
---|
4 | | - | also REPRESENTATIVE(S) Mabrey and Young, Bacon, Bird, |
---|
5 | | - | Boesenecker, Duran, Epps, Froelich, Garcia, Gonzales-Gutierrez, Hamrick, |
---|
6 | | - | Herod, Jodeh, Joseph, Kipp, Lieder, Lindsay, Ortiz, Parenti, Snyder, Story, |
---|
7 | | - | Titone, Velasco, Willford. |
---|
| 9 | + | Senate Committees House Committees |
---|
| 10 | + | Health & Human Services Health & Insurance |
---|
| 11 | + | A BILL FOR AN ACT |
---|
9 | | - | ONCERNING PRESCRIPTION DRUGS FOR THE TREATMENT OF CHRONIC PAIN . |
---|
10 | | - | Be it enacted by the General Assembly of the State of Colorado: |
---|
11 | | - | SECTION 1. In Colorado Revised Statutes, add 12-30-109.5 as |
---|
12 | | - | follows: |
---|
13 | | - | 12-30-109.5. Prescription drugs for treatment of chronic pain - |
---|
14 | | - | patients - prescribers - definitions. (1) A |
---|
15 | | - | S USED IN THIS SECTION, UNLESS |
---|
16 | | - | THE CONTEXT OTHERWISE REQUIRES |
---|
17 | | - | : |
---|
| 13 | + | ONCERNING PRESCRIPTION DRUGS FOR THE TREATMENT OF CHRONIC101 |
---|
| 14 | + | PAIN.102 |
---|
| 15 | + | Bill Summary |
---|
| 16 | + | (Note: This summary applies to this bill as introduced and does |
---|
| 17 | + | not reflect any amendments that may be subsequently adopted. If this bill |
---|
| 18 | + | passes third reading in the house of introduction, a bill summary that |
---|
| 19 | + | applies to the reengrossed version of this bill will be available at |
---|
| 20 | + | http://leg.colorado.gov |
---|
| 21 | + | .) |
---|
| 22 | + | The bill allows a health-care provider to prescribe, dispense, or |
---|
| 23 | + | administer a schedule II, III, IV, or V controlled substance (drug) to a |
---|
| 24 | + | patient in the course of treatment for a diagnosed condition that causes |
---|
| 25 | + | chronic pain. The bill also clarifies that the prescribing health-care |
---|
| 26 | + | provider is not subject to disciplinary action by the appropriate regulator |
---|
| 27 | + | for prescribing a dosage of a drug that is equal to or more than a |
---|
| 28 | + | HOUSE |
---|
| 29 | + | 3rd Reading Unamended |
---|
| 30 | + | April 13, 2023 |
---|
| 31 | + | HOUSE |
---|
| 32 | + | Amended 2nd Reading |
---|
| 33 | + | April 12, 2023 |
---|
| 34 | + | SENATE |
---|
| 35 | + | 3rd Reading Unamended |
---|
| 36 | + | March 9, 2023 |
---|
| 37 | + | SENATE |
---|
| 38 | + | Amended 2nd Reading |
---|
| 39 | + | March 7, 2023 |
---|
| 40 | + | SENATE SPONSORSHIP |
---|
| 41 | + | Ginal, Marchman, Buckner, Fields, Gardner, Kirkmeyer, Liston, Lundeen, Pelton R., Rich, |
---|
| 42 | + | Smallwood, Van Winkle, Will, Zenzinger |
---|
| 43 | + | HOUSE SPONSORSHIP |
---|
| 44 | + | Mabrey and Young, Bacon, Bird, Boesenecker, Duran, Epps, Froelich, Garcia, Gonzales- |
---|
| 45 | + | Gutierrez, Hamrick, Herod, Jodeh, Joseph, Kipp, Lieder, Lindsay, Ortiz, Parenti, Snyder, |
---|
| 46 | + | Story, Titone, Velasco, Willford |
---|
| 47 | + | Shading denotes HOUSE amendment. Double underlining denotes SENATE amendment. |
---|
| 48 | + | Capital letters or bold & italic numbers indicate new material to be added to existing law. |
---|
| 49 | + | Dashes through the words or numbers indicate deletions from existing law. morphine milligram equivalent dosage recommendation or threshold |
---|
| 50 | + | specified in state or federal opioid prescribing guidelines or policies. |
---|
| 51 | + | The bill prohibits a health-care provider from refusing to accept or |
---|
| 52 | + | continue to treat a patient solely on the basis of the dosage of a drug the |
---|
| 53 | + | patient requires for the treatment of chronic pain. A health-care provider |
---|
| 54 | + | is also prohibited from tapering a needed dosage solely to meet a |
---|
| 55 | + | predetermined dosage recommendation. |
---|
| 56 | + | The bill also prohibits a pharmacist, health insurance carrier, or |
---|
| 57 | + | pharmacy benefit manager from refusing to fill or approve the coverage |
---|
| 58 | + | for a drug solely on the basis of the dosage requirement of a patient. |
---|
| 59 | + | Be it enacted by the General Assembly of the State of Colorado:1 |
---|
| 60 | + | SECTION 1. In Colorado Revised Statutes, add 12-30-109.5 as2 |
---|
| 61 | + | follows:3 |
---|
| 62 | + | 12-30-109.5. Prescription drugs for treatment of chronic pain4 |
---|
| 63 | + | - patients - prescribers - definitions. (1) A |
---|
| 64 | + | S USED IN THIS SECTION,5 |
---|
| 65 | + | UNLESS THE CONTEXT OTHERWISE REQUIRES :6 |
---|
22 | | - | HRONIC PAIN" MEANS A PAIN THAT TYPICALLY LASTS THREE |
---|
23 | | - | NOTE: This bill has been prepared for the signatures of the appropriate legislative |
---|
24 | | - | officers and the Governor. To determine whether the Governor has signed the bill |
---|
25 | | - | or taken other action on it, please consult the legislative status sheet, the legislative |
---|
26 | | - | history, or the Session Laws. |
---|
27 | | - | ________ |
---|
28 | | - | Capital letters or bold & italic numbers indicate new material added to existing law; dashes |
---|
29 | | - | through words or numbers indicate deletions from existing law and such material is not part of |
---|
30 | | - | the act. MONTHS OR LONGER AND MAY BE THE RESULT OF AN UNDERLYING MEDICAL |
---|
31 | | - | DISEASE OR CONDITION |
---|
32 | | - | , INJURY, MEDICAL TREATMENT, INFLAMMATION, OR |
---|
33 | | - | UNKNOWN CAUSE |
---|
34 | | - | . "CHRONIC PAIN" IS A PAIN STATE IN WHICH THE CAUSE OF |
---|
35 | | - | THE PAIN OFTEN CANNOT BE REMOVED WITH REAS ONABLE MEDICAL EFFORTS |
---|
36 | | - | AT THE CONSENT OF THE PATIENT |
---|
37 | | - | , OR PAIN FOR WHICH NO CURE CAN BE |
---|
38 | | - | FOUND AFTER REASONABLE MEDICAL EFFORTS |
---|
39 | | - | . CHRONIC PAIN MAY RESTRICT |
---|
40 | | - | THE ABILITY OF INDIVIDUALS TO WORK |
---|
41 | | - | , CARE FOR THEMSELVES , AND |
---|
42 | | - | ENGAGE IN BASIC LIFE |
---|
43 | | - | , SOCIAL, AND PHYSICAL ACTIVITIES. |
---|
| 71 | + | HRONIC PAIN" MEANS A PAIN THAT TYPICALLY LASTS |
---|
| 72 | + | 9 |
---|
| 73 | + | THREE MONTHS OR LONGER AND MAY BE THE RESULT OF AN UNDERLYING10 |
---|
| 74 | + | MEDICAL DISEASE OR CONDITION , INJURY, MEDICAL TREATMENT ,11 |
---|
| 75 | + | INFLAMMATION, OR UNKNOWN CAUSE. "CHRONIC PAIN" IS A PAIN STATE12 |
---|
| 76 | + | IN WHICH THE CAUSE OF THE PAIN OFTEN CANNOT BE REMOVED WITH13 |
---|
| 77 | + | REASONABLE MEDICAL EFFORTS AT THE CONSENT OF THE PATIENT , OR PAIN14 |
---|
| 78 | + | FOR WHICH NO CURE CAN BE FOUND AFTER REASONABLE MEDICAL15 |
---|
| 79 | + | EFFORTS. CHRONIC PAIN MAY RESTRICT THE ABILITY OF INDIVIDUALS TO16 |
---|
| 80 | + | WORK, CARE FOR THEMSELVES, AND ENGAGE IN BASIC LIFE, SOCIAL, AND17 |
---|
| 81 | + | PHYSICAL ACTIVITIES.18 |
---|
59 | | - | HEN TREATING A NONTERMINALLY ILL PATIENT FOR CHRONIC |
---|
60 | | - | PAIN |
---|
61 | | - | , AN EVALUATION CONDUCTED BY THE TREATING HEALTH -CARE |
---|
62 | | - | PROVIDER OR A HEALTH |
---|
63 | | - | -CARE PROVIDER SPECIALIZING IN PAIN MEDICINE OR |
---|
64 | | - | TREATMENT OF THE AREA |
---|
65 | | - | , SYSTEM, OR ORGAN OF THE BODY CONFIRMED OR |
---|
66 | | - | PERCEIVED AS THE SOURCE OF THE CHRONIC PAIN |
---|
67 | | - | ; OR |
---|
68 | | - | (B) WHEN TREATING A TERMINALLY ILL PATIENT , AN EVALUATION |
---|
69 | | - | CONDUCTED BY THE TREATING HEALTH |
---|
70 | | - | -CARE PROVIDER WHO CONDUCTS THE |
---|
71 | | - | EVALUATION IN ACCORDANCE WITH THE STANDARD OF CARE AND THE LEVEL |
---|
72 | | - | OF CARE |
---|
73 | | - | , SKILL, AND TREATMENT THAT WOULD BE RECOGNIZED BY A |
---|
74 | | - | HEALTH |
---|
75 | | - | -CARE PROVIDER UNDER SIMILAR CONDITIONS AND CIRCUMSTANCES . |
---|
| 93 | + | HEN TREATING A NONTERMINALLY ILL PATIENT FOR CHRONIC7 |
---|
| 94 | + | PAIN, AN EVALUATION CONDUCTED BY THE TREATING HEALTH -CARE8 |
---|
| 95 | + | PROVIDER OR A HEALTH-CARE PROVIDER SPECIALIZING IN PAIN MEDICINE9 |
---|
| 96 | + | OR TREATMENT OF THE AREA , SYSTEM, OR ORGAN OF THE BODY10 |
---|
| 97 | + | CONFIRMED OR PERCEIVED AS THE SOURCE OF THE CHRONIC PAIN ; OR11 |
---|
| 98 | + | (B) W |
---|
| 99 | + | HEN TREATING A TERMINALLY ILL PATIENT, AN EVALUATION12 |
---|
| 100 | + | CONDUCTED BY THE TREATING HEALTH -CARE PROVIDER WHO CONDUCTS13 |
---|
| 101 | + | THE EVALUATION IN ACCORDANCE WITH THE STANDARD OF CARE AND THE14 |
---|
| 102 | + | LEVEL OF CARE, SKILL, AND TREATMENT THAT WOULD BE RECOGNIZED BY15 |
---|
| 103 | + | A HEALTH-CARE PROVIDER UNDER SIMILAR CONDITIONS AND16 |
---|
| 104 | + | CIRCUMSTANCES.17 |
---|
82 | | - | EALTH-CARE PROVIDER" MEANS A PHYSICIAN, A PHYSICIAN |
---|
83 | | - | ASSISTANT |
---|
84 | | - | , OR AN ADVANCED PRACTICE REGISTERED NURSE LICENSED |
---|
85 | | - | PURSUANT TO THIS TITLE |
---|
86 | | - | 12. |
---|
87 | | - | (e) "R |
---|
88 | | - | ARE DISEASE" MEANS A DISEASE, DISORDER, OR CONDITION |
---|
89 | | - | PAGE 2-SENATE BILL 23-144 THAT AFFECTS FEWER THAN TWO HUNDRED THOUSAND INDIVIDUALS IN THE |
---|
90 | | - | UNITED STATES AND IS CHRONIC , SERIOUS, LIFE-ALTERING, OR |
---|
91 | | - | LIFE |
---|
92 | | - | -THREATENING. |
---|
93 | | - | (f) "S |
---|
94 | | - | CHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE" MEANS A |
---|
95 | | - | CONTROLLED SUBSTANCE AS DESCRIBED IN SECTION |
---|
96 | | - | 18-18-204, 18-18-205, |
---|
97 | | - | 18-18-206, |
---|
98 | | - | OR 18-18-207, RESPECTIVELY. |
---|
99 | | - | (2) Criteria for the evaluation and treatment of chronic pain. |
---|
| 110 | + | EALTH-CARE PROVIDER" MEANS A PHYSICIAN, A PHYSICIAN21 |
---|
| 111 | + | ASSISTANT, OR AN ADVANCED PRACTICE REGISTERED NURSE LICENSED22 |
---|
| 112 | + | PURSUANT TO THIS TITLE 12.23 |
---|
| 113 | + | |
---|
| 114 | + | 24 |
---|
| 115 | + | (e) "RARE DISEASE" MEANS A DISEASE, DISORDER, OR CONDITION25 |
---|
| 116 | + | THAT AFFECTS FEWER THAN TWO HUNDRED THOUSAND INDIVIDUALS IN26 |
---|
| 117 | + | THE UNITED STATES AND IS CHRONIC, SERIOUS, LIFE-ALTERING, OR27 |
---|
| 118 | + | 144 |
---|
| 119 | + | -3- LIFE-THREATENING.1 |
---|
| 120 | + | (f) "SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE" MEANS2 |
---|
| 121 | + | A CONTROLLED SUBSTANCE AS DESCRIBED IN SECTION 18-18-204,3 |
---|
| 122 | + | 18-18-205, |
---|
| 123 | + | 18-18-206, OR 18-18-207, RESPECTIVELY.4 |
---|
| 124 | + | (2) Criteria for the evaluation and treatment of chronic pain.5 |
---|
107 | | - | DIAGNOSIS OF A CONDITION CAUSING CHRONIC PAIN BY THE |
---|
108 | | - | TREATING HEALTH |
---|
109 | | - | -CARE PROVIDER OR A HEALTH -CARE PROVIDER |
---|
110 | | - | SPECIALIZING IN PAIN MEDICINE OR TREATMENT OF THE AREA |
---|
111 | | - | , SYSTEM, OR |
---|
112 | | - | ORGAN OF THE BODY CONFIRMED OR PERCEIVED AS THE SOURCE OF THE PAIN |
---|
113 | | - | THAT IS SUFFICIENT TO MEET THE DEFINITION OF CHRONIC PAIN |
---|
114 | | - | ; AND |
---|
115 | | - | (b) THE CAUSE OF THE DIAGNOSIS OF CHRONIC PAIN MUST NOT |
---|
116 | | - | INTERFERE WITH MEDICALLY NECESSARY TREATMENT |
---|
117 | | - | , INCLUDING BUT NOT |
---|
118 | | - | LIMITED TO PRESCRIBING OR ADMINISTERING A SCHEDULE |
---|
119 | | - | II, III, IV, OR V |
---|
120 | | - | CONTROLLED SUBSTANCE . |
---|
121 | | - | (3) Prescription and administration of controlled substances for |
---|
122 | | - | chronic pain. (a) N |
---|
123 | | - | OTWITHSTANDING ANY OTHER PROVISION OF LAW , A |
---|
124 | | - | HEALTH |
---|
125 | | - | -CARE PROVIDER MAY PRESCRIBE , DISPENSE, OR ADMINISTER A |
---|
126 | | - | SCHEDULE |
---|
127 | | - | II, III, IV, OR V CONTROLLED SUBSTANCE TO A PATIENT IN THE |
---|
128 | | - | COURSE OF THE HEALTH |
---|
129 | | - | -CARE PROVIDER'S TREATMENT OF THE PATIENT FOR |
---|
130 | | - | A DIAGNOSED CONDITION CAUSING CHRONIC PAIN |
---|
131 | | - | . A HEALTH-CARE |
---|
132 | | - | PROVIDER IS NOT SUBJECT TO DISCIPLINARY ACTION BY THE REGULATOR FOR |
---|
133 | | - | APPROPRIATELY PRESCRIBING |
---|
134 | | - | , DISPENSING, OR ADMINISTERING A SCHEDULE |
---|
135 | | - | II, III, IV, OR V CONTROLLED SUBSTANCE IN THE COURSE OF TREATMENT OF |
---|
136 | | - | A PATIENT FOR CHRONIC PAIN IF THE HEALTH |
---|
137 | | - | -CARE PROVIDER KEEPS |
---|
138 | | - | ACCURATE RECORDS OF THE PURPOSE |
---|
139 | | - | , USE, PRESCRIPTION, AND DISPOSAL OF |
---|
140 | | - | THE CONTROLLED SUBSTANCE |
---|
141 | | - | , WRITES ACCURATE PRESCRIPTIONS , AND |
---|
142 | | - | PRESCRIBES MEDICATIONS IN ACCORDANCE WITH LEGITIMATE MEDICAL |
---|
143 | | - | PURPOSE IN THE USUAL COURSE OF PROFESSIONAL PRACTICE |
---|
144 | | - | . |
---|
| 130 | + | DIAGNOSIS OF A CONDITION CAUSING CHRONIC PAIN BY THE9 |
---|
| 131 | + | TREATING HEALTH-CARE PROVIDER OR A HEALTH -CARE PROVIDER10 |
---|
| 132 | + | SPECIALIZING IN PAIN MEDICINE OR TREATMENT OF THE AREA , SYSTEM, OR11 |
---|
| 133 | + | ORGAN OF THE BODY CONFIRMED OR PERCEIVED AS THE SOURCE OF THE12 |
---|
| 134 | + | PAIN THAT IS SUFFICIENT TO MEET THE DEFINITION OF CHRONIC PAIN; AND13 |
---|
| 135 | + | (b) T |
---|
| 136 | + | HE CAUSE OF THE DIAGNOSIS OF CHRONIC PAIN MUST NOT14 |
---|
| 137 | + | INTERFERE WITH MEDICALLY NECESSARY TREATMENT , INCLUDING BUT15 |
---|
| 138 | + | NOT LIMITED TO PRESCRIBING OR ADMINISTERING A SCHEDULE II, III, IV,16 |
---|
| 139 | + | OR V CONTROLLED SUBSTANCE.17 |
---|
| 140 | + | (3) Prescription and administration of controlled substances18 |
---|
| 141 | + | for chronic pain. (a) N |
---|
| 142 | + | OTWITHSTANDING ANY OTHER PROVISION OF LAW ,19 |
---|
| 143 | + | A HEALTH-CARE PROVIDER MAY PRESCRIBE , DISPENSE, OR ADMINISTER A20 |
---|
| 144 | + | SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE TO A PATIENT IN THE21 |
---|
| 145 | + | COURSE OF THE HEALTH-CARE PROVIDER'S TREATMENT OF THE PATIENT22 |
---|
| 146 | + | FOR A DIAGNOSED CONDITION CAUSING CHRONIC PAIN . A HEALTH-CARE23 |
---|
| 147 | + | PROVIDER IS NOT SUBJECT TO DISCIPLINARY ACTION BY THE REGULATOR24 |
---|
| 148 | + | FOR APPROPRIATELY PRESCRIBING , DISPENSING, OR ADMINISTERING A25 |
---|
| 149 | + | SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE IN THE COURSE OF26 |
---|
| 150 | + | TREATMENT OF A PATIENT FOR CHRONIC PAIN IF THE HEALTH -CARE27 |
---|
| 151 | + | 144 |
---|
| 152 | + | -4- PROVIDER KEEPS ACCURATE RECORDS OF THE PURPOSE , USE,1 |
---|
| 153 | + | PRESCRIPTION, AND DISPOSAL OF THE CONTROLLED SUBSTANCE , WRITES2 |
---|
| 154 | + | ACCURATE PRESCRIPTIONS , AND PRESCRIBES MEDICATIONS IN3 |
---|
| 155 | + | ACCORDANCE WITH LEGITIMATE MEDICAL PURPOSE IN THE USUAL COURSE 4 |
---|
| 156 | + | OF PROFESSIONAL PRACTICE.5 |
---|
156 | | - | PAIN BY PRESCRIBING |
---|
157 | | - | , DISPENSING, OR ADMINISTERING ONE OR MORE |
---|
158 | | - | SCHEDULE |
---|
159 | | - | II, III, IV, OR V CONTROLLED SUBSTANCES THAT INCLUDE , BUT |
---|
160 | | - | ARE NOT LIMITED TO |
---|
161 | | - | , OPIOID ANALGESICS SHALL NOT BE REQUIRED TO TAPER |
---|
162 | | - | A PATIENT |
---|
163 | | - | 'S MEDICATION DOSAGE SOLELY TO MEET A PREDETERMINED |
---|
164 | | - | MORPHINE MILLIGRAM EQUIVALENT DOSAGE RECOMMENDATION OR |
---|
165 | | - | THRESHOLD IF THE PATIENT IS STABLE AND COMPLIANT WITH THE |
---|
166 | | - | TREATMENT PLAN AND IS NOT EXPERIENCING SERIOUS HARM FROM THE |
---|
167 | | - | LEVEL OF MEDICATION CURRENTLY BEING PRESCRIBED OR PREVIOUSLY |
---|
168 | | - | PRESCRIBED |
---|
169 | | - | . A DECISION TO TAPER OR MAINTAIN MEDICATION MUST |
---|
170 | | - | INCLUDE AN INDIVIDUALIZED ASSESSMENT OF THE PATIENT |
---|
171 | | - | 'S CURRENT |
---|
172 | | - | MEDICAL CONDITION AND TREATMENT PLAN |
---|
173 | | - | , THE RISKS AND BENEFITS OF |
---|
174 | | - | MAINTAINING OR TAPERING THE PATIENT |
---|
175 | | - | 'S MEDICATION, AND A DISCUSSION |
---|
176 | | - | WITH THE PATIENT |
---|
177 | | - | . |
---|
178 | | - | (d) (I) A |
---|
179 | | - | PHARMACY, CARRIER, OR PHARMACY BENEFIT MANAGER |
---|
180 | | - | SHALL NOT HAVE A POLICY IN PLACE THAT REQUIRES THE PHARMACIST TO |
---|
181 | | - | REFUSE TO FILL A PRESCRIPTION FOR AN OPIATE ISSUED BY A HEALTH |
---|
182 | | - | -CARE |
---|
183 | | - | PROVIDER WITH THE AUTHORITY TO PRESCRIBE OPIATES SOLELY BECAUSE |
---|
184 | | - | THE PRESCRIPTION IS FOR AN OPIATE OR BECAUSE THE PRESCRIPTION ORDER |
---|
185 | | - | EXCEEDS A PREDETERMINED MORPHINE MILLIGRAM EQUIVALENT DOSAGE |
---|
186 | | - | RECOMMENDATION OR THRESHOLD |
---|
187 | | - | . |
---|
| 169 | + | 14 |
---|
| 170 | + | PAIN BY PRESCRIBING, DISPENSING, OR ADMINISTERING ONE OR MORE15 |
---|
| 171 | + | SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCES THAT INCLUDE , BUT16 |
---|
| 172 | + | ARE NOT LIMITED TO, OPIOID ANALGESICS SHALL NOT BE REQUIRED TO17 |
---|
| 173 | + | TAPER A PATIENT 'S MEDICATION DOSAGE SOLELY TO MEET A18 |
---|
| 174 | + | PREDETERMINED MORPHINE MILLIGRAM EQUIVALENT DOSAGE19 |
---|
| 175 | + | RECOMMENDATION OR THRESHOLD IF THE PATIENT IS STABLE AND20 |
---|
| 176 | + | COMPLIANT WITH THE TREATMENT PLAN AND IS NOT EXPERIENCING21 |
---|
| 177 | + | SERIOUS HARM FROM THE LEVEL OF MEDICATION CURRENTLY BEING22 |
---|
| 178 | + | PRESCRIBED OR PREVIOUSLY PRESCRIBED . A DECISION TO TAPER OR23 |
---|
| 179 | + | MAINTAIN MEDICATION MUST INCLUDE AN INDIVIDUALIZED ASSESSMENT24 |
---|
| 180 | + | OF THE PATIENT'S CURRENT MEDICAL CONDITION AND TREATMENT PLAN ,25 |
---|
| 181 | + | THE RISKS AND BENEFITS OF MAINTAINING OR TAPERING THE PATIENT 'S26 |
---|
| 182 | + | MEDICATION, AND A DISCUSSION WITH THE PATIENT.27 |
---|
| 183 | + | 144 |
---|
| 184 | + | -5- (d) (I) A PHARMACY, CARRIER, OR PHARMACY BENEFIT MANAGER1 |
---|
| 185 | + | SHALL NOT HAVE A POLICY IN PLACE THAT REQUIRES THE PHARMACIST TO2 |
---|
| 186 | + | REFUSE TO FILL A PRESCRIPTION FOR AN OPIATE ISSUED BY A HEALTH-CARE3 |
---|
| 187 | + | PROVIDER WITH THE AUTHORITY TO PRESCRIBE OPIATES SOLELY BECAUSE4 |
---|
| 188 | + | THE PRESCRIPTION IS FOR AN OPIATE OR BECAUSE THE PRESCRIPTION5 |
---|
| 189 | + | ORDER EXCEEDS A PREDETERMINED MORPHINE MILLIGRAM EQUIVALENT6 |
---|
| 190 | + | DOSAGE RECOMMENDATION OR THRESHOLD .7 |
---|
189 | | - | HEALTH-CARE PRACTICE OR CLINIC IN WHICH A HEALTH-CARE |
---|
190 | | - | PROVIDER IS AUTHORIZED TO PRESCRIBE SCHEDULE |
---|
191 | | - | II, III, IV, OR V |
---|
192 | | - | CONTROLLED SUBSTANCES SHALL NOT HAVE A POLICY IN PLACE THAT |
---|
193 | | - | REQUIRES THE HEALTH |
---|
194 | | - | -CARE PROVIDER TO REFUSE TO PRESCRIBE , |
---|
195 | | - | ADMINISTER, OR DISPENSE A PRESCRIPTION FOR AN OPIATE SOLELY BECAUSE |
---|
196 | | - | THE PRESCRIPTION EXCEEDS A PREDETERMINED MORPHINE MILLIGRAM |
---|
197 | | - | EQUIVALENT DOSAGE RECOMMENDATION OR THRESHOLD |
---|
198 | | - | . |
---|
199 | | - | (e) B |
---|
200 | | - | EFORE TREATING A PATIENT FOR CHRONIC PAIN IN ACCORDANCE |
---|
201 | | - | WITH THIS SUBSECTION |
---|
202 | | - | (3), A HEALTH-CARE PROVIDER SHALL DISCUSS WITH |
---|
203 | | - | PAGE 4-SENATE BILL 23-144 THE PATIENT OR THE PATIENT'S LEGAL GUARDIAN, IF APPLICABLE, THE RISKS |
---|
204 | | - | ASSOCIATED WITH THE SCHEDULE |
---|
205 | | - | II, III, IV, OR V CONTROLLED SUBSTANCE |
---|
206 | | - | TO BE PRESCRIBED OR ADMINISTERED IN THE COURSE OF THE HEALTH |
---|
207 | | - | -CARE |
---|
208 | | - | PROVIDER |
---|
209 | | - | 'S TREATMENT OF THE PATIENT AND DOCUMENT THE DISCUSSION |
---|
210 | | - | IN THE PATIENT |
---|
211 | | - | 'S RECORD. |
---|
212 | | - | (4) Limits on applicability. (a) T |
---|
213 | | - | HIS SECTION DOES NOT APPLY TO: |
---|
214 | | - | (I) A |
---|
215 | | - | HEALTH-CARE PROVIDER'S TREATMENT OF A PATIENT FOR A |
---|
216 | | - | SUBSTANCE USE DISORDER RESULTING FROM THE USE OF A SCHEDULE |
---|
217 | | - | II, III, |
---|
| 192 | + | HEALTH-CARE PRACTICE OR CLINIC IN WHICH A |
---|
| 193 | + | 8 |
---|
| 194 | + | HEALTH-CARE PROVIDER IS AUTHORIZED TO PRESCRIBE SCHEDULE II, III,9 |
---|
219 | | - | OR V CONTROLLED SUBSTANCE; |
---|
220 | | - | (II) T |
---|
221 | | - | HE PRESCRIPTION OR ADMINISTRATION OF A SCHEDULE II, III, |
---|
222 | | - | IV, |
---|
223 | | - | OR V CONTROLLED SUBSTANCE TO A PATIENT WHOM THE HEALTH -CARE |
---|
224 | | - | PROVIDER KNOWS TO BE USING THE CONTROLLED SUBSTANCE FOR |
---|
225 | | - | NONTHERAPEUTIC OR DRUG DIVERSION PURPOSES |
---|
226 | | - | ; |
---|
227 | | - | (III) T |
---|
228 | | - | HE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A |
---|
229 | | - | SCHEDULE |
---|
230 | | - | II, III, IV, OR V CONTROLLED SUBSTANCE FOR THE PURPOSE OF |
---|
231 | | - | TERMINATING THE LIFE OF A PATIENT WITH CHRONIC PAIN |
---|
232 | | - | ; OR |
---|
233 | | - | (IV) THE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A |
---|
234 | | - | SCHEDULE |
---|
235 | | - | II, III, IV, OR V CONTROLLED SUBSTANCE THAT IS NOT A |
---|
236 | | - | CONTROLLED SUBSTANCE APPROVED BY THE FEDERAL FOOD AND DRUG |
---|
237 | | - | ADMINISTRATION FOR PAIN RELIEF |
---|
238 | | - | . |
---|
239 | | - | (b) T |
---|
240 | | - | HIS SECTION DOES NOT LIMIT THE POWERS AND DUTIES OF THE |
---|
241 | | - | COLORADO MEDICAL BOARD PURSUANT TO SECTION 12-240-106 OR THE |
---|
242 | | - | STATE BOARD OF NURSING PURSUANT TO SECTION |
---|
243 | | - | 12-255-107. |
---|
244 | | - | SECTION 2. Safety clause. The general assembly hereby finds, |
---|
245 | | - | PAGE 5-SENATE BILL 23-144 determines, and declares that this act is necessary for the immediate |
---|
246 | | - | preservation of the public peace, health, or safety. |
---|
247 | | - | ____________________________ ____________________________ |
---|
248 | | - | Steve Fenberg |
---|
249 | | - | Julie McCluskie |
---|
250 | | - | PRESIDENT OF SPEAKER OF THE HOUSE |
---|
251 | | - | THE SENATE OF REPRESENTATIVES |
---|
252 | | - | ____________________________ ____________________________ |
---|
253 | | - | Cindi L. Markwell Robin Jones |
---|
254 | | - | SECRETARY OF CHIEF CLERK OF THE HOUSE |
---|
255 | | - | THE SENATE OF REPRESENTATIVES |
---|
256 | | - | APPROVED________________________________________ |
---|
257 | | - | (Date and Time) |
---|
258 | | - | _________________________________________ |
---|
259 | | - | Jared S. Polis |
---|
260 | | - | GOVERNOR OF THE STATE OF COLORADO |
---|
261 | | - | PAGE 6-SENATE BILL 23-144 |
---|
| 196 | + | OR V CONTROLLED SUBSTANCES SHALL NOT HAVE A POLICY IN PLACE |
---|
| 197 | + | 10 |
---|
| 198 | + | THAT REQUIRES THE HEALTH-CARE PROVIDER TO REFUSE TO PRESCRIBE ,11 |
---|
| 199 | + | ADMINISTER, OR DISPENSE A PRESCRIPTION FOR AN OPIATE SOLELY12 |
---|
| 200 | + | BECAUSE THE PRESCRIPTION EXCEEDS A PREDETERMINED MORPHINE13 |
---|
| 201 | + | MILLIGRAM EQUIVALENT DOSAGE RECOMMENDATION OR THRESHOLD .14 |
---|
| 202 | + | (e) BEFORE TREATING A PATIENT FOR CHRONIC PAIN IN15 |
---|
| 203 | + | ACCORDANCE WITH THIS SUBSECTION (3), A HEALTH-CARE PROVIDER16 |
---|
| 204 | + | SHALL DISCUSS WITH THE PATIENT OR THE PATIENT'S LEGAL GUARDIAN, IF17 |
---|
| 205 | + | APPLICABLE, THE RISKS ASSOCIATED WITH THE SCHEDULE II, III, IV, OR V18 |
---|
| 206 | + | CONTROLLED SUBSTANCE TO BE PRESCRIBED OR ADMINISTERED IN THE19 |
---|
| 207 | + | COURSE OF THE HEALTH-CARE PROVIDER'S TREATMENT OF THE PATIENT20 |
---|
| 208 | + | AND DOCUMENT THE DISCUSSION IN THE PATIENT 'S RECORD.21 |
---|
| 209 | + | (4) Limits on applicability. (a) THIS SECTION DOES NOT APPLY22 |
---|
| 210 | + | TO:23 |
---|
| 211 | + | (I) A HEALTH-CARE PROVIDER'S TREATMENT OF A PATIENT FOR A24 |
---|
| 212 | + | SUBSTANCE USE DISORDER RESULTING FROM THE USE OF A SCHEDULE II,25 |
---|
| 213 | + | III, |
---|
| 214 | + | IV, OR V CONTROLLED SUBSTANCE;26 (II) THE PRESCRIPTION OR ADMINISTRATION OF A SCHEDULE II, III,27 |
---|
| 215 | + | 144 |
---|
| 216 | + | -6- IV, OR V CONTROLLED SUBSTANCE TO A PATIENT WHOM THE1 |
---|
| 217 | + | HEALTH-CARE PROVIDER KNOWS TO BE USING THE CONTROLLED2 |
---|
| 218 | + | SUBSTANCE FOR NONTHERAPEUTIC OR DRUG DIVERSION PURPOSES ;3 |
---|
| 219 | + | (III) THE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A4 |
---|
| 220 | + | SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE FOR THE PURPOSE OF5 |
---|
| 221 | + | TERMINATING THE LIFE OF A PATIENT WITH CHRONIC PAIN ; OR6 |
---|
| 222 | + | (IV) THE PRESCRIPTION, DISPENSING, OR ADMINISTRATION OF A7 |
---|
| 223 | + | SCHEDULE II, III, IV, OR V CONTROLLED SUBSTANCE THAT IS NOT A8 |
---|
| 224 | + | CONTROLLED SUBSTANCE APPROVED BY THE FEDERAL FOOD AND DRUG9 |
---|
| 225 | + | ADMINISTRATION FOR PAIN RELIEF.10 |
---|
| 226 | + | (b) THIS SECTION DOES NOT LIMIT THE POWERS AND DUTIES OF THE11 |
---|
| 227 | + | COLORADO MEDICAL BOARD PURSUANT TO SECTION 12-240-106 OR THE12 |
---|
| 228 | + | STATE BOARD OF NURSING PURSUANT TO SECTION 12-255-107.13 |
---|
| 229 | + | SECTION 2. Safety clause. The general assembly hereby finds,14 |
---|
| 230 | + | determines, and declares that this act is necessary for the immediate15 |
---|
| 231 | + | preservation of the public peace, health, or safety.16 |
---|
| 232 | + | 144 |
---|
| 233 | + | -7- |
---|